Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in AXSOME THERAPEUTICS INC.
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 94,937 shares of AXSM (AXSOME THERAPEUTICS INC.), worth $16M as of 2026-Q1. The position was increased (+8.8% shares). AXSM represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$16M
Current Shares
94,937
Total Value Change
+$11.5M
Total Shares Change
+38,744
Other major holders of AXSM: BNP PARIBAS FINANCIAL MARKETS, CAPITAL FUND MANAGEMENT S.A., VANGUARD GROUP INC
Increased |
| 94,937 |
+8.8% |
| $16M |
| 0.0% |
| $164.05 |
31 |
| 2025-Q4 | Increased | 87,249 | +0.6% | $15.9M | 0.0% | $148.79 | 28 |
| 2025-Q3 | Decreased | 86,691 | -35.4% | $10.5M | 0.0% | $117.62 | 0 |
| 2025-Q2 | Increased | 134,101 | +79.1% | $14M | 0.0% | $103.36 | 43 |
| 2025-Q1 | Increased | 74,892 | +29.9% | $8.7M | 0.0% | $118.53 | 35 |
| 2024-Q4 | Increased | 57,642 | +20.8% | $4.9M | 0.0% | $84.78 | 32 |
| 2024-Q3 | Decreased | 47,714 | -15.1% | $4.3M | 0.0% | $89.64 | 0 |
| 2024-Q2 | Increased | 56,193 | +94.8% | $4.5M | 0.0% | $80.50 | 43 |